A detailed history of Huntington National Bank transactions in Pfizer Inc stock. As of the latest transaction made, Huntington National Bank holds 740,355 shares of PFE stock, worth $19.5 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
740,355
Previous 762,875 2.95%
Holding current value
$19.5 Million
Previous $21.3 Million 0.37%
% of portfolio
0.16%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$27.7 - $31.39 $623,804 - $706,902
-22,520 Reduced 2.95%
740,355 $21.4 Million
Q2 2024

Aug 08, 2024

SELL
$25.26 - $29.6 $799,958 - $937,402
-31,669 Reduced 3.99%
762,875 $21.3 Million
Q1 2024

May 03, 2024

SELL
$25.89 - $29.73 $3.13 Million - $3.6 Million
-121,009 Reduced 13.22%
794,544 $22 Million
Q4 2023

Feb 07, 2024

SELL
$26.13 - $33.94 $2.21 Million - $2.87 Million
-84,658 Reduced 8.46%
915,553 $26.4 Million
Q3 2023

Nov 08, 2023

SELL
$32.09 - $37.51 $1.36 Million - $1.59 Million
-42,423 Reduced 4.07%
1,000,211 $33.2 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $259,630 - $300,386
-7,188 Reduced 0.68%
1,042,634 $38.2 Million
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $788,548 - $1.03 Million
-20,019 Reduced 1.87%
1,049,822 $42.8 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $1.53 Million - $2 Million
-36,711 Reduced 3.32%
1,069,841 $54.8 Million
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $185,804 - $226,821
4,246 Added 0.39%
1,106,552 $48.4 Million
Q2 2022

Aug 09, 2022

BUY
$46.53 - $55.17 $2.46 Million - $2.91 Million
52,790 Added 5.03%
1,102,306 $57.8 Million
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $11,117 - $13,775
243 Added 0.02%
1,049,516 $54.3 Million
Q4 2021

Jan 21, 2022

BUY
$41.32 - $61.25 $595,255 - $882,367
14,406 Added 1.39%
1,049,273 $62 Million
Q3 2021

Oct 28, 2021

SELL
$39.25 - $50.42 $1.59 Million - $2.04 Million
-40,555 Reduced 3.77%
1,034,867 $44.5 Million
Q2 2021

Jul 30, 2021

BUY
$35.91 - $40.68 $5.97 Million - $6.76 Million
166,149 Added 18.27%
1,075,422 $42.1 Million
Q1 2021

Apr 12, 2021

SELL
$33.49 - $37.77 $1.6 Million - $1.8 Million
-47,655 Reduced 4.98%
909,273 $32.9 Million
Q4 2020

Jan 11, 2021

SELL
$33.47 - $42.56 $768,069 - $976,666
-22,948 Reduced 2.34%
956,928 $35.2 Million
Q3 2020

Oct 30, 2020

SELL
$31.75 - $37.25 $1.14 Million - $1.34 Million
-35,861 Reduced 3.53%
979,876 $36 Million
Q2 2020

Jul 30, 2020

SELL
$30.12 - $36.54 $2.1 Million - $2.55 Million
-69,718 Reduced 6.42%
1,015,737 $33.2 Million
Q1 2020

Apr 27, 2020

SELL
$27.03 - $38.62 $2.17 Million - $3.1 Million
-80,242 Reduced 6.88%
1,085,455 $35.4 Million
Q4 2019

Jan 17, 2020

SELL
$32.92 - $37.36 $2.13 Million - $2.41 Million
-64,608 Reduced 5.25%
1,165,697 $45.7 Million
Q3 2019

Nov 01, 2019

SELL
$32.49 - $42.13 $3.12 Million - $4.05 Million
-96,043 Reduced 7.24%
1,230,305 $44.2 Million
Q2 2019

Jul 23, 2019

SELL
$36.98 - $41.52 $1.76 Million - $1.98 Million
-47,607 Reduced 3.46%
1,326,348 $57.5 Million
Q1 2019

Apr 09, 2019

SELL
$37.5 - $41.2 $3.12 Million - $3.42 Million
-83,120 Reduced 5.7%
1,373,955 $58.4 Million
Q4 2018

Jan 28, 2019

SELL
$38.47 - $43.86 $788,057 - $898,472
-20,485 Reduced 1.39%
1,457,075 $63.6 Million
Q3 2018

Oct 18, 2018

SELL
$34.47 - $41.81 $2.59 Million - $3.15 Million
-75,259 Reduced 4.85%
1,477,560 $65.1 Million
Q2 2018

Jul 19, 2018

SELL
$32.98 - $35.16 $4.33 Million - $4.61 Million
-131,252 Reduced 7.79%
1,552,819 $56.3 Million
Q1 2018

Apr 30, 2018

SELL
$31.91 - $37.02 $7.99 Million - $9.27 Million
-250,466 Reduced 12.95%
1,684,071 $59.8 Million
Q4 2017

Feb 02, 2018

BUY
$33.26 - $35.29 $881,123 - $934,902
26,492 Added 1.39%
1,934,537 $70.1 Million
Q3 2017

Oct 24, 2017

BUY
$31.0 - $34.15 $59.1 Million - $65.2 Million
1,908,045
1,908,045 $68.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.